[Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
D000477:Alkylating Agents / Q000037:antagonists & inhibitors; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000037:antagonists & inhibitors; D000964:Antimetabolites, Antineoplastic / Q000037:antagonists & inhibitors; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors; D003561:Cytarabine / Q000037:antagonists & inhibitors; D004351:Drug Resistance; D004357:Drug Synergism; D006801:Humans; D008967:Molecular Biology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics; D010641:Phenotype; D011687:Purines / Q000037:antagonists & inhibitors; D011741:Pyrimidine Nucleosides / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000037:antagonists & inhibitors
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D011687:Purines; D011741:Pyrimidine Nucleosides; D011743:Pyrimidines; D003561:Cytarabine
Molekuliarnye mekhanizmy vozniknoveniia lekarstvennoĭ ustoĭchivosti opukholeĭ i puti ee preodoleniia.